Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC

Clinical trial NCT03291002 · UNKNOWN

Trial details

NCT number: NCT03291002
Sponsor: CureVac
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)Squamous Cell Carcinoma of the Skin Carcinoma, Squamous Cell of Head and Neck Carcinoma, Adenoid Cystic

Start date: 2017-09-25
Primary completion: 2022-10-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.